Molipaxin (Trazodone Hydrochloride)

Trazodone Hydrochloride, the active ingredient in Molipaxin, is a serotonin antagonist and reuptake inhibitor (SARI) presented as an oral dosage form for oral use. It is prescribed for the treatment of major depressive disorder in adult patients.

GNH USA supplies Molipaxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare providers worldwide, with a focus on quality and regulatory compliance.

Molipaxin (trazodone hydrochloride) is used in the management of depressive disorders by modulating serotonergic pathways.

- Major depressive disorder: reduces depressive symptoms and improves mood in adult patients. - Depressive disorder with insomnia: assists in improving sleep while treating depressive symptoms. - Anxiety associated with depression: may lessen anxiety symptoms in patients who have co‑existing depressive illness.

Trazodone may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects: - Dizziness - Drowsiness or somnolence - Dry mouth - Headache - Nausea - Blurred vision

Serious or Rare Side Effects: - Priapism (prolonged erection) - Serotonin syndrome when combined with other serotonergic drugs - Cardiac arrhythmias or QT prolongation - Severe hypotension - Hepatic injury - Emergence of suicidal thoughts or behaviors

When prescribing Molipaxin, clinicians should consider several safety measures.

- Psychiatric assessment: evaluate for suicidal ideation before and during therapy. - Hepatic function: use caution in patients with liver impairment and monitor liver enzymes. - Elderly patients: start at lower doses and titrate slowly due to increased sensitivity. - Discontinuation: avoid abrupt cessation to reduce risk of withdrawal symptoms. - Concomitant CNS depressants: monitor for additive sedation. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Trazodone can interact with a variety of medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Other serotonergic agents (e.g., SSRIs, SNRIs, tramadol, linezolid): may precipitate serotonin toxicity. - Alcohol: enhances sedative effects and can increase dizziness.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise trazodone plasma levels. - Antihypertensive drugs: additive hypotensive effect. - Central nervous system depressants (e.g., benzodiazepines, antihistamines): monitor for excessive sedation.